Successful Treatment of Cutaneous Scedosporium prolificans: An Emerging and Treatment-Resistant Fungal Pathogen

Area of Science:

• Mycology
• Infectious Diseases
• Dermatology

Background:

• Scedosporium prolificans is an opportunistic fungal pathogen known for its resistance to standard antifungal treatments.
• This fungus can lead to diverse clinical presentations, from skin infections to systemic disease.

Observation:

• A case study of a 41-year-old immunocompetent male with biopsy-proven Scedosporium prolificans cutaneous infection is presented.
• The patient exhibited significant clinical improvement after a two-month course of combined oral itraconazole and minocycline therapy.

Findings:

• Scedosporium prolificans demonstrates resistance to numerous antifungal agents, often leading to treatment failure with monotherapy.
• Combination therapy with minocycline and azole antifungals, such as itraconazole, shows synergistic effects against S. prolificans.

Implications:

• This case highlights the efficacy of combining minocycline with itraconazole for treating S. prolificans infections.
• Timely and effective combination oral therapy can prevent disease progression, reduce the risk of disseminated infection, and potentially avoid surgical intervention.